FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a wound healing product, and can be used in treating wounds and burns of animals. Wound healing agent containing laevomycetin, boric acid, Vaseline, glycerin and distilled water, wherein the agent additionally contains an active substance and novocaine, active ingredient is a complex of biologically active polypeptides, having antioxidant and geroprotective action, with molecular weight 1,000–12,000 Da, recovered from epiphysis of animals, with certain ratio of components.
EFFECT: agent described above has higher efficacy in treating infected and burn wounds.
1 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF BURN (VARIANTS) AND METHOD FOR ITS PREPARING (VARIANTS) | 2006 |
|
RU2317811C1 |
AGENT FOR HEALING WOUNDS | 1992 |
|
RU2040252C1 |
AGENT "POLIMED" FOR EXTERNAL USE | 1998 |
|
RU2140264C1 |
BURN TREATMENT AGENT | 2024 |
|
RU2825001C1 |
HYDROPHILIC PHARMACEUTICAL COMPOSITION FOR TREATMENT OF BURNS (VERSIONS) | 2008 |
|
RU2404745C2 |
AGENT FOR ACCELERATING WOUND HEALING AND TISSUE REGENERATION | 2014 |
|
RU2549987C1 |
ANTI-BURN AGENT BASED ON ASPEN LEAVES, FLOWERS OF CALENDULA, WILD CAMOMILE | 2016 |
|
RU2618087C1 |
WOUND-HEALING DRUG | 2012 |
|
RU2517065C1 |
AGENT FOR TREATMENT OF WOUNDS, BURNS AND INFLAMMATORY SKIN DISEASES | 2020 |
|
RU2744545C1 |
Authors
Dates
2019-12-18—Published
2019-02-07—Filed